Law firm dedicated to the protection, transfer and enforcement of intellectual property rights.
Mar 27, 2023 • 112 tweets • 22 min read
Good morning! Will Milliken here. I’m a director in Sterne Kessler’s Trial and Appeals Group and co-chair of the firm’s Appellate Practice. I’ll be providing real-time analysis of today’s #SCOTUS argument in #Amgen v. Sanofi. #AppellateTwitter#SCOTUSLive 1/
The #Amgen case concerns the standard for the patent-law requirement of "enablement," found in section 112 of the Patent Act. 2/
Oct 12, 2022 • 122 tweets • 21 min read
Good morning! Will Milliken here. I’m a director in Sterne Kessler’s Trial and Appeals Group. I’ll be live-tweeting today’s #SCOTUS argument in Andy #Warhol Foundation for the Visual Arts v. Goldsmith. #AppellateTwitter 1/
The #Warhol case concerns the scope of the “fair use” defense to copyright infringement, and, specifically, whether Andy Warhol’s “Orange Prince” work is a fair use of the Lynn Goldsmith photograph on which it was based. 2/
Apr 21, 2021 • 132 tweets • 42 min read
Good morning! Will Milliken here. I’m a director in Sterne Kessler’s Trial and Appeals Group. I’ll be live-tweeting today’s #SCOTUS arguments in #Minerva v. Hologic, which involves everyone’s favorite* patent-law doctrine, assignor estoppel.
*ymmv #AppellateTwitter 1/
If you joined us last month for Sterne Kessler’s inaugural SCOTUS-argument live-tweet for the #Arthrex case, welcome back!
Good morning everyone. Will Milliken here. I’m a director in Sterne Kessler’s Trial and Appeals Group and I am here live*-tweeting this morning’s arguments in United States v. Arthrex.
*But I am not a cat. #AppellateTwitter#Arthrex 1/
This case concerns the constitutionality of the Patent Trial and Appeal Board. It’s a big deal for those of us who practice patent law: the PTAB is a MAJOR feature of patent litigation today. The decision here could have very significant impacts. 2/
